News & articles

Click HERE to subscribe and receive future editions of our Under the Microscope electronic publication and/or our print newsletter, MPN Update, conveniently delivered to your email or home mailbox! 2024:  Fall | Summer | Spring  2023:  Fall  |  Summer  |  Spring  2022: Fall  |  Summer |  Spring 2021: Fall  |  Summer  |  Spring 2020: Fall  |  Summer  |  Spring 2019: Fall  |  Spring 2018: Fall  |  Spring 2017: Fall  |  Spring… Read More »Newsletter archive

The MPN Research Foundation is reaching out to the MPN patient community to raise awareness about an opportunity for patients 18 years of age or older with Myeloproliferative Neoplasms (MPN). Patients who qualify can support research by providing a one-time blood donation from home. The blood sample will be collected by a mobile medical professional… Read More »Help Advance Myeloproliferative Neoplasms (MPN) Research from Home and Earn $100

December 2010 The American Society of Clinical Oncology (ASCO) recently released three videos of renowned MPD specialists discussing various topics related to MPDs. Drs. Ayalew Tefferi, William Vainchencker and James Vardiman contributed to the series. Click here to view videos

December 2010 Online chat and support group MPD-Chat has listed all abstracts presented at the recent American Society of Hematology meeting that are relevant to MPD/MPN. Take a look at the abstract as well as the discussion boards. Thanks to MPD Chat for compiling this list!

The MPD Foundation is pleased to announce the recipients of our Research Alliance and New Investigator grants for 2009. This follows an extensive proposal review process conducted by our Scientific Advisory Board as well as additional MPD experts who gave generously of their time and expertise. Listed below are the grantee names, institutions and project… Read More »2009 GRANT ANNOUNCEMENT

This is an abstract that was presented at ASH’s annual meeting on Sunday, December 7, 2008: 4:45 PM 304-306-308 – South (Moscone Center) JAK2 V617F has been identified as a constitutive activating mutation in approximately half of patients with myelofibrosis (MF). MF, a myeloproliferative disorder comprised of primary myelofibrosis and the clinically indistinguishable entities of… Read More »A PHASE I STUDY OF XL019, A SELECTIVE JAK2 INHIBITOR, IN PATIENTS WITH PRIMARY MYELOFIBROSIS, POST-POLYCYTHEMIA VERA, OR POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS

Drs. Ron Hoffman and John Mascerenhas of Mt. Sinai School of Medicine in New York have reported positive outcomes from their Phase I trial of panobinostat in myelofibrosis patients. Their article published in the British Journal of Haematology states that significant improvement occurred for patients on low dosages of Panobinostat. Click here for the full… Read More »PANOBINOSTAT MF TRIALS PHASE I

Dr. Laura Michaelis of Loyola recently contributed to the MPN Advocacy and Education International’s site to educate people on special issues related to Polycythemia Vera and Essential Thrombocythemia. Dr. Michaelis, who co-chairs the MPN Chicago Roundtable, covers topics such as hormone supplements, surgery risks, venous clotting and more. Click here to read the full article.

June 13, 2013 By Robert Rosen The American Society of Clinical Oncologist just wrapped up its annual meeting in Chicago last week. The meeting brought together over 25,000 oncology professionals from all disciplines. Added to the fertile mix were drug companies, advocacy folks and journalists striving to understand what’s new in cancer research and treatment.… Read More »MPN NEWS FROM ASCO 2013

June 13, 2013 On June 1, 2013, the MPN Research Foundation and the Leukemia & Lymphoma Society brought together 13 researchers from within and outside the MPNs to review the 2nd round of MF Challenge grant proposals. The meeting was held in a conference space within Northwestern in downtown Chicago where the feasibility, innovative quality… Read More »MF CHALLENGE REVIEW MEETING